Future Perspectives and Unanswered Questions on Cancer Metastasis and the Lymphovascular System

  • Stanley P. L. Leong
  • Marlys H. Witte
Part of the Cancer Treatment and Research book series (CTAR, volume 135)

For the clinical oncologist, the most humbling experience is when the cancer has spread and the disease is unresponsive to available therapy to curb progression.Paget developed the “seed and soil” hypothesis to explain the phenomenon of clinical cancer metastasis (1). Since the work of Paget, we have seen explosive advances in biological understanding of the mechanisms of metastasis. Numerous animal models have been applied to further understand the cellular and molecular mechanisms of cancer metastasis (2). But the translational link to the clinic from such basic science advances continues to remain elusive. It is important, therefore, to bring clinicians and basic scientists together to share their knowledge and perspectives on the phenomena surrounding cancer metastasis. For this reason, the first International Symposium on Cancer Metastasis and the Lymphovascular System was organized and successfully held in San Francisco in April 2005. The meeting highlights have been summarized in the June issue of 2006 Cancer Metastasis Reviews.


Acute Myeloid Leukemia Cancer Metastasis Lymphatic Channel Tumorigenic Breast Cancer Cell Invade Cancer Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Paget S (1989) The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev 8: 98–101.PubMedGoogle Scholar
  2. 2.
    Hoon DS, Kitago M, Kim J, Mori T, Piris A, Szyfelbein K, Mihm MC Jr, Nathanson SD, Padera TP, Chambers AF, Vantyghem SA, MacDonald IC, Shivers SC, Alsarraj M, Reintgen DS, Passlick B, Sienel W, Pantel K (2006) Molecular mechanisms of metastasis. Cancer Metastasis Rev 25: 203–220.PubMedCrossRefGoogle Scholar
  3. 3.
    Witte MH, Jones K, Wilting J, Dictor M, Selg M, McHale N, Gershenwald JE, Jackson DG (2006) Structure function relationships in the lymphatic system and implications for cancer biology. Cancer Metastasis Rev 25: 159–184.PubMedCrossRefGoogle Scholar
  4. 4.
    Clarke MF, Becker MW (2006) Stem cells: the real culprits in cancer? Sci Am 295: 52–59.PubMedCrossRefGoogle Scholar
  5. 5.
    Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caliguiri MA, Dick JE (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367: 645–68.PubMedCrossRefGoogle Scholar
  6. 6.
    Hope KJ, Jin L, Dick JE (2003) Human acute myeloid leukemia stem cells. Arch Med Res 34: 507–514.PubMedCrossRefGoogle Scholar
  7. 7.
    Al-Hajj M, Wicha MSA, Benito-Herdandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983–3988.PubMedCrossRefGoogle Scholar
  8. 8.
    Roco MC (2006) Nanotechnology’s future. Sci Am 295: 39.PubMedCrossRefGoogle Scholar
  9. 9.
    Suri C (2006) The emergence of molecular and transgenic lymphology: what do we (really) know so far? Lymphology 39: 1–7.PubMedGoogle Scholar
  10. 10.
    Witte MH, Witte C (2999) What we don’t know about cancer. In: Otter W, Root-Bernstein R, Koten JW (eds.) What is cancer? Anticancer Res 19: 4919–4934.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Stanley P. L. Leong
    • 1
  • Marlys H. Witte
    • 2
  1. 1.Department of SurgeryUniversity of California San Francisco and UCSF Comprehensive Cancer Center at Mount ZionSan FranciscoUSA
  2. 2.Department of SurgeryUniversity of Arizona College of MedicineTucsonUSA

Personalised recommendations